Your SlideShare is downloading. ×
National Chlamydia Coalition 2010 Evaluation
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

National Chlamydia Coalition 2010 Evaluation

666
views

Published on

Presented by Sonal Doshi, Health Scientist, Division of STD Prevention, Centers for Disease Control and Prevention, and Victoria Beltran, ORISE Fellow, Division of STD Prevention, Centers for Disease …

Presented by Sonal Doshi, Health Scientist, Division of STD Prevention, Centers for Disease Control and Prevention, and Victoria Beltran, ORISE Fellow, Division of STD Prevention, Centers for Disease Control and Prevention, at the 2010 National Chlamydia Coalition meeting.

Published in: Health & Medicine

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
666
On Slideshare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Victoria Beltran, DSTDP/HSREB Sonal R. Doshi, DSTDP/HSREB National Chlamydia Coalition Meeting October 28, 2010 National Chlamydia Coalition 2010 Evaluation Division of STD Prevention National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention 1
  • 2. Overview  Background  Purpose  Methods  CDC Evaluation Framework  Evaluation Sub-Committee  Evaluation Focus  Timeline  Where We Are Now  Next Steps 2
  • 3. Background  There is a movement towards increasing use of coalitions in public health  Few studies exist documenting effectiveness of coalitions  Fewer models exist to evaluate effectiveness of coalition work in public health  No studies exist evaluating effectiveness of coalitions focused on STDs 3
  • 4. Purpose  Evaluate the effectiveness of the NCC, including its internal operations and impact of the coalition on members and other stakeholders  Document key factors that have contributed to NCC’s success  Document the process of coalition development so that lessons learned can be used for developing future coalitions  Highlight strengths and accomplishments of NCC to inform for example, additional potential funders, internal and external to CDC 4
  • 5. Methods: CDC Evaluation Framework Centers for Disease Control and Prevention.  Framework for Program Evaluation in Public Health. MMWR 1999;48(No. RR-11). 5
  • 6. Methods: Evaluation Sub-committee NCC Keith Barton, MD Policy and Advocacy Committee Gail Burstein, MD, MPH, FAAP Provider Education Committee Research Committee* Yvonne Hamby, MPH Public Awareness Committee Karen Shea, WHNP-BC Provider Education Committee Partnership for Prevention Christianne Johnson, MA, CHES Susan Maloney, MHS Alana Ward, MPP, MST CDC/DSTDP Staff Victoria Beltran, MPH, CHES Sonal R. Doshi, MS, MPH Penny Loosier, MA, MPH Raul Romaguera, DMD, MPH * Requests for subcommittee volunteers was prior to Research Committee formation 6
  • 7. Methods: Evaluation Focus  Process evaluation: document whether a program has been implemented as intended—“implementation fidelity”— and why or why not?  To document the level of success in achieving objectives  To identify areas of the program that need improvement  To improve the content of the program’s materials  To solicit more funds or additional partners http://www.cdc.gov/eval/evalguide.pdf 7
  • 8. Methods: Timeline 8
  • 9. Where We Are Now  Member survey is open on Zoomerang  Open until MONDAY NOVEMBER 1, 2010  Recruit participants for interviews  Conduct phone interviews with select members in November 9
  • 10. Next Steps  Analyze member survey results  Conduct phone interviews  Analyze results  Complete final version of logic model  Prepare evaluation report for subcommittee feedback  Revise as necessary 10
  • 11. For more information please contact Centers for Disease Control and Prevention 1600 Clifton Road NE, Atlanta, GA 30333 Telephone, 1-800-CDC-INFO (232-4636)/TTY: 1-888-232-6348 E-mail: cdcinfo@cdc.gov Web: www.cdc.gov The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. Thank you! Questions? Comments? For more information, please contact: Sonal R. Doshi Victoria Beltran sdoshi@cdc.gov or vbeltran@cdc.gov 404-639-6209 404-639-8270 National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Division of STD Prevention 11